-10.8%
GSK vs KRMN
-65.5%
+54.7%
-16.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | KRMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | -11.3% | +11.4% | +1.2% |
| 7D | -3.6% | -12.9% | +9.3% | -2.5% |
| 30D | -5.9% | -43.3% | +37.4% | -1.1% |
| 3M | -4.3% | -27.2% | +22.9% | -2.4% |
| 6M | -10.8% | -66.8% | +56.0% | -1.3% |
| All | -10.8% | -65.5% | +54.7% | -1.3% |
Cumulative growth
Daily Returns
Daily percentage return beside KRMN.
Daily Out/Under-Performance
Portfolio return minus KRMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded KRMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling